Ciprodex and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ciprodex (ciprofloxacin; dexamethasone) and Humalog (insulin lispro recombinant). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ciprodex and Humalog. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Ciprodex?

Ciprodex has active ingredients of ciprofloxacin; dexamethasone. It is often used in otitis. eHealthMe is studying from 1,887 Ciprodex users. Check the latest studies of Ciprodex.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

On Jul, 19, 2026

48 people who take Ciprodex and Humalog together, and have interactions are studied.

What are the common drug interactions of Ciprodex and Humalog, by gender? *:

female:

Chronic kidney disease
Dehydration (dryness resulting from the removal of water)
Dizziness
Abscess (pus)
Cellulitis (infection under the skin)
Perirectal abscess
Sepsis (a severe blood infection that can lead to organ failure and death)
Blood glucose increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Erythrasma (skin disease that causes brown, scaly skin patches)

male:

Chronic kidney disease
Back disorder
Oedema peripheral (superficial swelling)
Paralysis
Renal failure (kidney dysfunction)
Thrombosis (formation of a blood clot inside a blood vessel)
Viral infection
Blood pressure decreased
Dizziness
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Ciprodex and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dehydration (dryness resulting from the removal of water)
Dizziness
Erythrasma (skin disease that causes brown, scaly skin patches)
Cough
Diarrhoea
Headache (pain in head)
Influenza
Infusion site haemorrhage (bleeding from infusion site)
Injection site extravasation (flow of (blood or lymph) from injection site)
Injection site nerve damage

50-59:

Abscess (pus)
Cellulitis (infection under the skin)
Perirectal abscess
Sepsis (a severe blood infection that can lead to organ failure and death)
Abscess limb (limb infection)
Anal abscess
Chronic kidney disease
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dermal cyst
Drug intolerance (drug sensitivity)

60+:

Chronic kidney disease
Blood glucose increased
Disease progression
Drug hypersensitivity
Drug ineffective
Eructation (release of gas from the digestive tract)
Flushing (the warm, red condition of human skin)
Hyperglycaemia (high blood sugar)
Impaired gastric emptying
Injection site pain

What are the existing conditions these people have? *

Drowsiness: 13 people, 27.08%
High Blood Pressure: 11 people, 22.92%
Type 1 Diabetes: 6 people, 12.50%
Pain: 6 people, 12.50%
Asthma: 6 people, 12.50%
Stress And Anxiety: 5 people, 10.42%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 10.42%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 10.42%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 10.42%
Type 2 Diabetes: 4 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ciprodex and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously